Kazia Therapeutics Ltd (KZIA) stock
KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
$5.49+0.18 (+3.39%)
Close on Nov 18, 2026Market cap $8.89MP/E –Yield –
Kazia Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Kazia Therapeutics's price to book ratio was 0.7× on Jan 31, 2024, against 1.6× a year earlier. Over the last 5 years it ranged from 0.6× to 11.8×, with a median of 2.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jan 31, 2024 | 0.7× | −0.3 |
| 2023 | Dec 29, 2023 | 1.0× | +0.3 |
| 2022 | Dec 30, 2022 | 0.6× | −3.0 |
| 2021 | Dec 31, 2021 | 3.6× | −2.2 |
| 2020 | Dec 31, 2020 | 5.8× | +3.3 |
| 2019 | Dec 31, 2019 | 2.5× | +1.6 |
| 2018 | Dec 31, 2018 | 0.9× | −6.6 |
| 2017 | Dec 29, 2017 | 7.5× | – |
See a number that looks wrong?